Loading clinical trials...

Dispensing Evaluation of Subjective Comfort, Vision, and Handling of a New Lens Compared to a Marketed Lens | Clinical Trials | Clareo Health

COMPLETEDNA

Dispensing Evaluation of Subjective Comfort, Vision, and Handling of a New Lens Compared to a Marketed Lens

Dispensing Evaluation of Lens Comfort and Subjective Vision of an Etafilcon A With Print and PVP Lens for Dark Eyes

NCT01484054•Johnson & Johnson Vision Care, Inc.

View on ClinicalTrials.gov

Summary

To evaluate and compare the performance of a new contact lens to a marketed contact lens.

Eligibility

Age

18 - 34 years

Sex

FEMALE

Healthy Volunteers

Inclusion Criteria

•The subject must be a healthy adult at least 18 years of age and no more than 34 years of age.
•The subjects must be female, dark eye Caucasian, Non-Hispanic habitual soft contact lens wearer (both eyes).

Exclusion Criteria

•The subject must have no known ocular or systemic allergies that might interfere with contact lens wear.
•The subject must have no known systemic disease, or need for medication, which might interfere with contact lens wear.
•The subject's optimal vertexed spherical equivalent distance correction must be between-1.00 and -4.00D.
•Any cylinder power must be:\<=0.75D.
•The subject must have visual acuity best correctable to 20/25 or better for each eye.
•The subject must have normal eyes (no ocular medications or ocular infection of any type).
•The subject must read and sign the Statement of Informed Consent.
•The subject must appear able and willing to adhere to the instructions set forth in this clinical protocol.
•Ocular or systemic allergies or disease which might interfere with contact lens wear.
•Systemic disease, autoimmune disease, or use of medication which might interfere with contact lens wear.
+12 more criteria

Locations (6)

Bloomfield, Connecticut, United States

Tallahassee, Florida, United States

Overland Park, Kansas, United States

Jamestown, New York, United States

Kingston, Pennsylvania, United States

Moon Township, Pennsylvania, United States

Key Dates

Start Date

November 1, 2011

Primary Completion Date

February 1, 2012

Completion Date

February 1, 2012

Last Updated

June 19, 2018

Enrollment

103

ACTUAL participants

Conditions

Refractive Ametropia

Interventions

etafilcon A with print and PVP for dark eyes (EAPVPDE)

DEVICE

etafilcon A control lens (EADE)

DEVICE

A Study to Evaluate the Clinical Performance and Safety of UNICON Silicone Hydrogel Daily Disposable Soft Contact Lenses

NCT07322211

Refractive Ametropia

View study

COMPLETEDNA

1-Week Dispensing Evaluation of REVIVE™ Toric Soft Contact Lenses

NCT06053736

Refractive Ametropia

View study

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: June 19, 2018Data synced to Clareo: March 29, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions